SATYA VANI NANNAPANENI's Insider Trades & SAST Disclosures
SATYA VANI NANNAPANENI's most recent trade in Natco Pharma Ltd. was a Acquisition of 420,000 Equity Shares done . Disclosure was reported to the exchange on March 3, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
SATYA VANI NANNAPANENI's has made SAST transactions in Natco Pharma Ltd. recently where a Acquisition of 420,000 shares done . Disclosure was reported to the exchange on March 3, 2025.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Natco Pharma | Satya Vani Nannapaneni | Promoter | Acquisition | 26 Mar 2025 | 420,000 | 420,000 (0.23%) | 0.23% | - | 28 Feb 2025 28 Feb 2025 |
SAST (29(1)) | - | Transmission | |
| Natco Pharma | SATYA VANI NANNAPANENI | Promoter Group | Acquisition | 03 Mar 2025 | 420,000 | 420,000 (0.23%) | 0.23% | 0 | 0 | 28 Feb 2025 28 Feb 2025 |
Insider Trading | Equity Shares | Inheritance |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.